![](/img/cover-not-exists.png)
Phase II Study of Asparagine-Glycine-Arginine-Human Tumor Necrosis Factor , a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma
Gregorc, V., Zucali, P. A., Santoro, A., Ceresoli, G. L., Citterio, G., De Pas, T. M., Zilembo, N., De Vincenzo, F., Simonelli, M., Rossoni, G., Spreafico, A., Grazia Vigano, M., Fontana, F., De BraudVolume:
28
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2009.27.3649
Date:
May, 2010
File:
PDF, 231 KB
english, 2010